Positive Results of Revascor presented, Mesoblast Ltd (ASX: MSB)
November 17th, 2010
No comments
ASX: MSB’s Revascor, an allogeneic (“off-the-shelf”) stem cell product can be injected simply, safely, and effectively into the coronary arteries after a heart attack to prevent heart failure. Read more…
Categories: ASX: MSB, Mesoblast Ltd, Revascor (TM), Stem Cell Technology
